STx@2x

ExPERT STx®

The industry’s leading scalable electroporation technology for high-yield, transient expression of complex proteins, vaccines and biologics

Rapidly transfect up to 20 billion cells

Proprietary Flow Electroporation® technology

Closed, cGMP-compliant system, 21 CFR part 11 compliant, ISO-certified and CE-marked

Improved yields, at scale, can decrease development timelines and, paired with flexible media strategies, deliver significant cost savings

Faster production of stable clones

Ideal for large-scale cell therapy optimization, training, process development and feasibility studies from early product development to pre-IND validation studies

Row PDPstickymenuWave Shape Decorative svg added to bottom
Row herosectionWave Shape Decorative svg added to top

Product features

Integrated touch screen - Easily operate with just the touch of a finger.

Enhanced software user interface - Save time with updated software, providing additional functionality and intuitive use.

Reduced footprint - Bench-scale, modular equipment saves valuable lab space.

Network capable - Generate and save run reports automatically onto a shared local drive.

LED status indicators - Quickly visualize instrument and run status with six colorful and clearly defined status modes.

Retractable bag hooks - Utilize convenient hooks for large volume processing and then fold them away when you don’t need them.

Elegant design - Enjoy a modern, sleek appearance that fits seamlessly into any high-tech lab space.

Row transparentWave Shape Decorative svg added to top
maxcyte-expert-img@2x

Choosing MaxCyte® gives you more than just an instrument — you get the best cell engineering platform and a partner with the knowledge to support you to reach your research and manufacturing goals

Row herosectionWave Shape Decorative svg added to top
Row seperator3 Shape Decorative svg added to bottom
Supporting products

Compatible consumables & accessories

5-r-20k-kit@2x

R-20K Flow Electroporation MaxCyte’s Flow Electroporation processing assemblies are designed for automated processing with optional adaptability to closed-process workflows.

Features:

  • 5 mL to 20 mL working volume
  • 200 million – 4 billion cell capability
  • PVC bag and tubing
  • Tapered bag design to allow maximum volume recovery
  • 2 access luer locking syringe ports at both sample and collection bags
Hyclone-Buffer@2x

Buffers Our proprietary buffer is available in multiple formats to address your workflow needs.

Features:

  • Use with all MaxCyte instrument platforms
  • Made in a GMP facility
  • Free of human or animal components
  • 0.1 µm filtered
  • Meets technical, sterility and endotoxin specifications
CL-2-Single-Top

CL-2 RUO Transfect up to 20 billion cells in less than 30 minutes with this Flow Electroporation enabled processing assembly.

Features:

  • Shake flask to bioreactor production scales
  • Closed system and biowelding-compatible
  • Flow Electroporation enables processing of up to 20 billion cells in 30 minutes
  • Made of high grade and inert material to protect precious cells
PA_5_in_rack_right

Px5 Workflow Rack Easily and securely hold, load, manage and transport up to five small-volume processing assemblies.

Features:

  • Holds 1 to 5 small volume PAs (≤1 ml)
  • “To Do” and “Done” positions for tracking PA workflow status
  • Durable, stackable, low footprint
  • Withstands common lab disinfectants

Find more consumables

Research applications

Viral Vector Production

Transfect adherent or suspension cells to produce a variety of viral vectors.

Cell Based Assays

Produce assay-ready cells faster with scalable electroporation.

Gene Editing

Navigate the complexities of genome engineering with highly efficient delivery.

Antibody & Protein Production

Accelerate biotherapeutic development with transient expression for gram-scale protein production.

Vaccine

Innovate vaccine research with our adaptable platform for production of recombinant proteins, virus-like particles and more.

Row seperator3 Shape Decorative svg added to top

Learn how scientists are using the STx™

pbio@2x

CRISPR-Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation

Gene editing of a suspension-adapted CHO cell line to enable production of suitably glycosylated HIV-1 proteins for vaccine development

Popular resources

Illustration of MaxCyte electroporation workflow for CAR NK production, for day 0 and days 1-3.
Scientific Brief
mRNA CAR NK Cells as Potential Anti-Sarcoma, Solid Tumor Therapy
CRISPR-MGAT1-gene@2x
Poster
CRISPR-Mediated Engineering of CHO Cell Lines: CHO-S and CHO-K1 Case Studies
ATE-images@2x
Poster
Achieving Therapeutic Efficacy with a High-Performance, Electroporation-Based Cellular Engineering Technology
View all resources

FAQ

Still have questions?